Roles of PPARs in health and disease, Nature, vol.405, pp.421-424, 2000. ,
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene, Embo J, vol.15, pp.5336-5348, 1996. ,
Peroxisome proliferator-activated receptors in the cardiovascular system, British Journal of Pharmacology, vol.272, issue.5, pp.823-834, 2000. ,
DOI : 10.1038/sj.bjp.0703149
Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor ??, Journal of Biological Chemistry, vol.273, issue.37, pp.23786-92, 1998. ,
DOI : 10.1074/jbc.273.37.23786
Peroxisome Proliferator-activated Receptor ?? Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-??B and AP-1, Journal of Biological Chemistry, vol.274, issue.45, pp.32048-32054, 1999. ,
DOI : 10.1074/jbc.274.45.32048
Peroxisome Proliferator??Activated Receptor Activators Target Human Endothelial Cells to Inhibit Leukocyte??Endothelial Cell Interaction, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.9, pp.2094-2104, 1999. ,
DOI : 10.1161/01.ATV.19.9.2094
Activation of Proliferator-activated Receptors ?? and ?? Induces Apoptosis of Human Monocyte-derived Macrophages, Journal of Biological Chemistry, vol.273, issue.40, pp.25573-25580, 1998. ,
DOI : 10.1074/jbc.273.40.25573
PPAR?? Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages, Circulation, vol.103, issue.2, pp.207-212, 2001. ,
DOI : 10.1161/01.CIR.103.2.207
PPAR?? Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes, Circulation, vol.103, issue.2, pp.213-219, 2001. ,
DOI : 10.1161/01.CIR.103.2.213
Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor ?? (PPAR??), Journal of Biological Chemistry, vol.273, issue.10, pp.5678-5684, 1998. ,
DOI : 10.1074/jbc.273.10.5678
The role of the peroxisome proliferator-activated receptor ?? (PPAR??) in the control of cardiac lipid metabolism, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.60, issue.5-6, pp.339-343, 1999. ,
DOI : 10.1016/S0952-3278(99)80009-X
Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor ?? Associated with Age-dependent Cardiac Toxicity, Journal of Biological Chemistry, vol.275, issue.29, pp.22293-22299, 2000. ,
DOI : 10.1074/jbc.M000248200
PPAR Signaling in the Control of Cardiac Energy Metabolism, Trends in Cardiovascular Medicine, vol.10, issue.6, pp.238-245, 2000. ,
DOI : 10.1016/S1050-1738(00)00077-3
Deactivation of peroxisome proliferator???activated receptor-?? during cardiac hypertrophic growth, Journal of Clinical Investigation, vol.105, issue.12, pp.1723-1730, 2000. ,
DOI : 10.1172/JCI9056
Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury, J. Biol. Chem, vol.271, pp.29223-29230, 1996. ,
Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts, Cardiovascular Research, vol.33, issue.2, pp.422-432, 1997. ,
DOI : 10.1016/S0008-6363(96)00254-4
Peroxisome Proliferator-activated Receptor alpha Activation Modulates Cellular Redox Status, Represses Nuclear Factor-kappa B Signaling, and Reduces Inflammatory Cytokine Production in Aging, Journal of Biological Chemistry, vol.273, issue.49, pp.32833-32841, 1998. ,
DOI : 10.1074/jbc.273.49.32833
The ligands/activators for peroxisome prolif- erator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu 2+ , Zn 2+ -superoxide dismutase and decrease p22phox message expressions in primary endothelial cells, pp.3-11, 2001. ,
Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis, Current Opinion in Lipidology, vol.10, issue.3, pp.245-57, 1999. ,
DOI : 10.1097/00041433-199906000-00007
PPAR agonists as direct modulators of the vessel wall in cardiovascular disease, Medicinal Research Reviews, vol.77, issue.5, pp.350-366, 2000. ,
DOI : 10.1002/1098-1128(200009)20:5<350::AID-MED2>3.0.CO;2-D
Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress, Circulation Research, vol.87, issue.10, pp.840-844, 2000. ,
DOI : 10.1161/01.RES.87.10.840
Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries, Circulation, vol.86, issue.4, pp.1302-1309, 1992. ,
DOI : 10.1161/01.CIR.86.4.1302
Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat, British Journal of Pharmacology, vol.311, issue.7, pp.1490-1494, 1995. ,
DOI : 10.1111/j.1476-5381.1995.tb13375.x
Nitric oxide and the regulation of gene expression, Trends in Cell Biology, vol.11, issue.2, pp.66-75, 2001. ,
DOI : 10.1016/S0962-8924(00)01900-0
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice., Journal of Clinical Investigation, vol.97, issue.11, pp.2408-2416, 1996. ,
DOI : 10.1172/JCI118687
Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome prolifearator-activator receptor-?, Blood, vol.93, pp.2991-2998, 1999. ,
Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate, Journal of Biological Chemistry, vol.276, issue.28, pp.25841-25847, 2001. ,
DOI : 10.1074/jbc.M101160200
Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats, Circulation Research, vol.41, issue.1, pp.19-26, 1977. ,
DOI : 10.1161/01.RES.41.1.19
Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line, Nucleic Acids Research, vol.10, issue.24, pp.7895-7903, 1982. ,
DOI : 10.1093/nar/10.24.7895